Lenalidomide combined with intensive chemotherapy in acute myeloid leukemia and higher-risk myelodysplastic syndrome with 5q deletion. Results of a phase II study by the Groupe Francophone Des Myélodysplasies.
about
Outcome of patients treated for myelodysplastic syndromes with 5q deletion after failure of lenalidomide therapy.Beyond the Edge of Hypomethylating Agents: Novel Combination Strategies for Older Adults with Advanced MDS and AML.IMiDs mobilize acute myeloid leukemia blasts to peripheral blood through downregulation of CXCR4 but fail to potentiate AraC/Idarubicin activity in preclinical models of non del5q/5q- AML
P2860
Lenalidomide combined with intensive chemotherapy in acute myeloid leukemia and higher-risk myelodysplastic syndrome with 5q deletion. Results of a phase II study by the Groupe Francophone Des Myélodysplasies.
description
2016 nî lūn-bûn
@nan
2016 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Lenalidomide combined with int ...... ancophone Des Myélodysplasies.
@ast
Lenalidomide combined with int ...... ancophone Des Myélodysplasies.
@en
Lenalidomide combined with int ...... ancophone Des Myélodysplasies.
@nl
type
label
Lenalidomide combined with int ...... ancophone Des Myélodysplasies.
@ast
Lenalidomide combined with int ...... ancophone Des Myélodysplasies.
@en
Lenalidomide combined with int ...... ancophone Des Myélodysplasies.
@nl
prefLabel
Lenalidomide combined with int ...... ancophone Des Myélodysplasies.
@ast
Lenalidomide combined with int ...... ancophone Des Myélodysplasies.
@en
Lenalidomide combined with int ...... ancophone Des Myélodysplasies.
@nl
P2093
P2860
P50
P1433
P1476
Lenalidomide combined with int ...... ancophone Des Myélodysplasies.
@en
P2093
Andrea Toma
Aspasia Stamatoullas
Cendrine Chaffaut
Christian Recher
Claude Gardin
Emmanuel Raffoux
Eric Wattel
Krimo Bouabdallah
Laure Stalnikiewicz
Lionel Ades
P2860
P304
P356
10.3324/HAEMATOL.2016.151894
P577
2016-12-29T00:00:00Z